Neurological Disease Services
-
Manufactured by RareStone Groupbased in CHINA
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of infectious diseases of the nervous system, neurodegenerative diseases, and neuromuscular ...
-
Manufactured by Creative Biolabsbased in CHINA
γδ T cells are a distinct subgroup of T cells that play a pivotal role in many neurological diseases. They are suggested to be responsible for inducing or maintaining the proinflammatory environment characteristic of these diseases. With access to advanced instruments, fit-for-purpose laboratories, and professional knowledge, Creative ...
-
Manufactured by Marsi Bionics, S.L.based in SPAIN
Bionics, in which other international public research bodies (hospitals, foundations, universities) and technology or health sector companies collaborate. Such a multidisciplinary public-private partnership will offer the most reliable diagnosis and innovative therapies for neurological diseases. In addition, research will allow the use of ...
-
based in USA
We are developing therapeutics that target senescence and adjacent biology with broad application across multiple indications with established endpoints and well-defined regulatory pathways to approval. Our initial focus is on delivering localized therapy in ophthalmologic and neurologic ...
-
Manufactured by Creative Biolabsbased in CHINA
neurological disease causing extensive plaque-like demyelination. This autoantibody response to MOG35-55 has been observed in MS patients and MOG35-55-induced EAE C57BL/6 mice and Lewis rats. ...
-
Manufactured by Creative Biolabsbased in CHINA
of diseases such as cancer, cardiovascular diseases, neurological diseases, autoimmune diseases and metabolic ...
-
Manufactured by Helius Medical Technologies, Inc.based in USA
with physical therapy can improve balance and gait deficit because of a mild to moderate traumatic brain injury (mmTBI) or multiple sclerosis (MS). Helius’ goal is to conduct further studies with PoNS® in neurological diseases and disorders, such as stroke, multiple sclerosis and cerebral ...
-
Manufactured by Sangamo Therapeuticsbased in USA
these are research efforts thoughtfully focused on leveraging our differentiated zinc finger technology. We are advancing a robust pipeline of wholly owned and partnered programs in rare disease, neurology, oncology and autoimmune indications with the goal of developing genomic medicines that transform the lives of ...
-
based in USA
CPM, Conditioned Pain Modulation, is one of our neural system mechanisms to control pain. CPM is an endogenous descending pain inhibition mechanism, located in the brain stem, the most “primitive” part of the brain, which is a critical area for nociception and pain ...
-
Manufactured by Acorda Therapeutics, Inc.based in USA
Acorda’s mission is to develop therapies to restore function and improve the lives of people with neurological disorders. Our company is devoted to supporting neurological research, education, and patient assistance through grant and sponsorship programs. We support a broad group of organizations based on the principles of ...
-
Manufactured by Stem Pharm, Incbased in USA
Stem Pharm offers a variety of services allowing for custom projects and biomaterials tailored to each customers’ ...
-
by Advancellsbased in INDIA
Amyotrophic Lateral Sclerosis, most commonly called as the Lou Gehrig’s disease or motor neuron disease is a type of a progressive neurological illness that manifests as gradual weakening and atrophy of muscles. The progression of the disease can go up to as many as two to five years but in very rare cases a person can live ...
-
Manufactured by NeuroOne Medical Technologies Corporationbased in USA
Neurons communicate through electrical and chemical signals. The specific properties of the neurons composing a brain area and their connections with neurons in other brain areas, define the function of a brain area (e.g. language, vision, ...
-
Manufactured by Mesoblast Ltd.based in AUSTRALIA
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as it develops its product candidates for major markets including the United States, Europe, Japan and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you